Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats

about

Amikacin: Uses, Resistance, and Prospects for Inhibition.Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.

P2860

Q52744431-24CEE56E-E693-450A-80DA-3E0789A5AB58 Q55057435-E78E430D-6040-4485-BBB0-5C511C713756

P2860

Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats

Item

http://www.wikidata.org/entity/Q37358621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pulmonary Deposition and Elimi ...... n after Administration in Rats

@en

Pulmonary Deposition and Elimi ...... after Administration in Rats.

@nl

type

Item

label

Pulmonary Deposition and Elimi ...... n after Administration in Rats

@en

Pulmonary Deposition and Elimi ...... after Administration in Rats.

@nl

prefLabel

Pulmonary Deposition and Elimi ...... n after Administration in Rats

@en

Pulmonary Deposition and Elimi ...... after Administration in Rats.

@nl

P1476

Pulmonary Deposition and Elimi ...... n after Administration in Rats

@en

P2093

Gina Eagle

http://www.w3.org/2001/XMLSchema#string

Mary Neville

http://www.w3.org/2001/XMLSchema#string

Renu Gupta

http://www.w3.org/2001/XMLSchema#string

Vladimir Malinin

http://www.w3.org/2001/XMLSchema#string

Walter R Perkins

http://www.w3.org/2001/XMLSchema#string

P2860

Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.

Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection

(99m)Tc-labeled therapeutic inhaled amikacin loaded liposomes.

In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial disease.

Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria.

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection

P304

6540-6549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00700-16

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27550345

http://www.w3.org/2001/XMLSchema#string

P921

macrophage

P932

5075057

http://www.w3.org/2001/XMLSchema#string

Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats

about

P2860

P2860

Pulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in Rats

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932